Endoscopic interventions in Barrett's esophagus: Do the dollars make sense?

Area of Science:

• Gastroenterology
• Endoscopic Medicine
• Health Economics

Background:

• Barrett's esophagus management is shifting towards endoscopic therapies for early neoplasia.
• These endoscopic interventions present an opportunity to alter the disease's natural progression.
• Evaluating the economic impact of these advanced treatments is crucial for healthcare integration.

Purpose of the Study:

• To review the existing literature on cost analyses of endoscopic interventions for Barrett's esophagus.
• To summarize the cost-effectiveness of these endoscopic treatments compared to traditional surveillance or surgical options.

Main Methods:

• Literature review of cost analyses for Barrett's endoscopic interventions.
• Synthesis of data comparing endoscopic therapy costs with surveillance and surgery.

Main Results:

• Endoscopic therapies for Barrett's esophagus are increasingly adopted.
• Cost-effectiveness data for these interventions are emerging.
• Comparisons with surveillance and surgery are essential for clinical and economic decision-making.

Conclusions:

• Endoscopic therapies represent a significant paradigm shift in managing early neoplasia in Barrett's esophagus.
• Clinical adoption of these modalities has substantial implications for disease management and healthcare costs.
• Cost-effectiveness data supports the integration of endoscopic interventions into standard care pathways.